Lessons learned from long-term multiple sclerosis treatment trials.
Marriott
James J
JJ
The MS Clinic, St Michael's Hospital, Division of Neurology, University of Toronto, Toronto, Canada.
O'Connor
Paul W
PW
D004185:Disability Evaluation; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D000068717:Glatiramer Acetate; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy*; D010455:Peptides / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D016896:Treatment Outcome
D007155:Immunologic Factors; D010455:Peptides; D000068717:Glatiramer Acetate